DK619884D0 - Farmaceutisk praeparat indeholdende en eller flere 1,2-diacyl-glycero-3-phosphocholiner - Google Patents

Farmaceutisk praeparat indeholdende en eller flere 1,2-diacyl-glycero-3-phosphocholiner

Info

Publication number
DK619884D0
DK619884D0 DK619884A DK619884A DK619884D0 DK 619884 D0 DK619884 D0 DK 619884D0 DK 619884 A DK619884 A DK 619884A DK 619884 A DK619884 A DK 619884A DK 619884 D0 DK619884 D0 DK 619884D0
Authority
DK
Denmark
Prior art keywords
phosphocholines
glycero
diacyl
pharmaceutical preparation
contain
Prior art date
Application number
DK619884A
Other languages
English (en)
Other versions
DK619884A (da
Inventor
Volker Schulz
Sigurd Leyck
Manfred Duerr
Miklos Ghyczy
Armin Wendel
Joerg Hager
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of DK619884D0 publication Critical patent/DK619884D0/da
Publication of DK619884A publication Critical patent/DK619884A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK619884A 1983-12-22 1984-12-21 Farmaceutisk praeparat indeholdende en eller flere 1,2-diacyl-glycero-3-phosphocholiner DK619884A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833346525 DE3346525A1 (de) 1983-12-22 1983-12-22 Pharmazeutische zubereitung mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich

Publications (2)

Publication Number Publication Date
DK619884D0 true DK619884D0 (da) 1984-12-21
DK619884A DK619884A (da) 1985-06-23

Family

ID=6217767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK619884A DK619884A (da) 1983-12-22 1984-12-21 Farmaceutisk praeparat indeholdende en eller flere 1,2-diacyl-glycero-3-phosphocholiner

Country Status (10)

Country Link
US (1) US4684632A (da)
EP (1) EP0147741B1 (da)
JP (1) JPS60169421A (da)
AT (1) ATE45091T1 (da)
DE (2) DE3346525A1 (da)
DK (1) DK619884A (da)
GR (1) GR82544B (da)
IE (1) IE57808B1 (da)
PT (1) PT79648B (da)
ZA (1) ZA849975B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
US4626527A (en) * 1985-09-28 1986-12-02 Massachusetts Institute Of Technology Process for utilizing choline to sustain muscular performance
DK153442C (da) * 1985-10-14 1988-12-19 Poul Bachmann Middel, baseret paa pektinholdigt materiale, til behandling og forebyggelse af diarre hos mennesker og dyr
DE3613799C1 (de) * 1986-04-24 1987-09-03 Nattermann A & Cie Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
EP0582239B1 (de) * 1992-08-04 1999-08-04 Rhone-Poulenc Rorer Gmbh Pharmazeutische und/oder kosmetische Zubereitung
GB9301629D0 (en) * 1993-01-27 1993-03-17 Scotia Holdings Plc Formulations containing unsaturated fatty acids
FR2714382B1 (fr) * 1993-12-27 1996-02-02 Roussel Uclaf Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
AU5794196A (en) * 1995-06-01 1996-12-18 G.D. Searle & Co. Stabilized solid dispersions of misoprostol
FR2779651B1 (fr) * 1998-06-16 2001-04-20 Gattefosse Ets Sa Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero
EP1492520A1 (en) * 2002-03-07 2005-01-05 Novartis AG Pharmaceutical compositions
BR0215680A (pt) * 2002-04-26 2005-02-01 Rudolf Perl Composição farmacêutica oral estável
CA2734284C (en) * 2008-11-20 2014-01-21 Techno Guard Co., Ltd. Pyrazolone derivative formulations
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド ｐＨ依存的再構築が可能な医薬キャリア、その製造方法及び使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
FR2343481A1 (fr) * 1976-03-11 1977-10-07 Gerlich Norbert Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees
JPS54117034A (en) * 1978-02-28 1979-09-11 Nippon Shoji Kk Treating agent for consciousness and perception motion disorder
DE2856333C2 (de) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung
JPS5562010A (en) * 1978-10-31 1980-05-10 Ajinomoto Co Inc Fat emulsion for intravenous injection
US4421747A (en) * 1978-12-27 1983-12-20 A. Nattermann & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
US4378354A (en) * 1978-12-27 1983-03-29 A. Nattermann & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
DE3047048A1 (de) * 1980-12-13 1982-07-29 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
DE3047011A1 (de) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
DE3047012A1 (de) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von acylierten phospholipiden aus diese enthaltenden phosphatidylcholin-produkten
DE3374914D1 (en) * 1982-04-12 1988-01-28 Univ Texas Methods and compositions for treating gastro-intestinal ulcer diesease

Also Published As

Publication number Publication date
DE3346525A1 (de) 1985-07-04
IE57808B1 (en) 1993-04-21
DE3346525C2 (da) 1987-03-19
US4684632A (en) 1987-08-04
ATE45091T1 (de) 1989-08-15
JPH0577653B2 (da) 1993-10-27
JPS60169421A (ja) 1985-09-02
DK619884A (da) 1985-06-23
GR82544B (en) 1985-04-24
PT79648B (de) 1986-10-21
EP0147741B1 (de) 1989-08-02
IE843263L (en) 1985-06-22
EP0147741A2 (de) 1985-07-10
ZA849975B (en) 1985-08-28
DE3479189D1 (en) 1989-09-07
PT79648A (de) 1985-01-01
EP0147741A3 (en) 1985-12-04

Similar Documents

Publication Publication Date Title
DK619884A (da) Farmaceutisk praeparat indeholdende en eller flere 1,2-diacyl-glycero-3-phosphocholiner
DE3172223D1 (en) Edible, pharmaceutical compositions and processes for making thereof
HUT40674A (en) Process for preparing inositol triphosphates and pharmaceutical compositions containing such compounds
IT1178235B (it) Composizioni farmaceutiche contenenti sucralfat e procedimento per la loro stabilizzazione
HU913010D0 (en) Method for producing inhibitors of calcium ingestion
HUT43080A (en) Compositions containing phospholipide and process for producing them
PT72507A (en) Process for the preparation of 3,4,5-trihydroxypiperidine derivatives having effect upon the carbohydrates and lipids metabolism and application thereof for the preparation of pharmaceutical and/or veterinary compositions having effect upon the carbohydrates and lipids metabolism
BE891639A (fr) Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine
ES502080A0 (es) Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina
DE3361990D1 (en) Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments
MX172808B (es) Trigliceridos que contienen acidos grasos saturados que tienen de 20 a 24 atomos de carbono utiles para disminuir los niveles de colesterol en la sangre
IL73849A (en) Pharmaceutical compositions containing phospholipids and oxicam derivatives and their production
GB2024010B (en) Compositions for containing fatty acids for the treatment of seborrhoeic conditions
GB2023145A (en) Hydrocortisone derivatives, their preparation and pharmaceutical compositions containing them
IT1212137B (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
NO913685L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
IT1119426B (it) Procedimento per la preparazione di derivati del ciclo 1 3 2 oxaza fosforile particolarmente utili come agenti anti cancro
ES2106922T3 (es) 3-beta-derivados de digitoxigenina y dihidrodigitoxigenina y composiciones farmaceuticas que los contienen para el tratamiento de la hipertension.

Legal Events

Date Code Title Description
ATS Application withdrawn